Ubs Asset Management Americas Inc Teva Pharmaceutical Industries LTD Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 3,377,517 shares of TEVA stock, worth $57.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,377,517
Previous 1,000,849 237.47%
Holding current value
$57.5 Million
Previous $16.3 Million 274.24%
% of portfolio
0.02%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$15.81 - $18.96 $37.6 Million - $45.1 Million
2,376,668 Added 237.47%
3,377,517 $60.9 Million
Q2 2024

Aug 13, 2024
SELL
$12.78 - $17.4 $15.6 Million - $21.3 Million
-1,222,615 Reduced 54.99%
1,000,849 $16.3 Million
Q1 2024

May 15, 2024
SELL
$10.67 - $14.43 $421,315 - $569,782
-39,486 Reduced 1.74%
2,223,464 $31.4 Million
Q4 2023

Feb 14, 2024
SELL
$8.12 - $10.63 $222,496 - $291,272
-27,401 Reduced 1.2%
2,262,950 $23.6 Million
Q3 2023

Nov 13, 2023
BUY
$7.48 - $10.7 $2.78 Million - $3.98 Million
371,868 Added 19.38%
2,290,351 $23.4 Million
Q1 2023

May 15, 2023
BUY
$8.36 - $11.37 $736,323 - $1 Million
88,077 Added 4.81%
1,918,483 $17 Million
Q4 2022

Feb 14, 2023
BUY
$7.95 - $9.48 $1.22 Million - $1.45 Million
153,181 Added 9.13%
1,830,406 $16.7 Million
Q3 2022

Nov 14, 2022
SELL
$6.86 - $11.95 $881,612 - $1.54 Million
-128,515 Reduced 7.12%
1,677,225 $13.5 Million
Q2 2022

Aug 12, 2022
BUY
$7.38 - $10.4 $44,132 - $62,192
5,980 Added 0.33%
1,805,740 $13.6 Million
Q1 2022

May 16, 2022
SELL
$7.33 - $9.39 $664,940 - $851,813
-90,715 Reduced 4.8%
1,799,760 $16.9 Million
Q4 2021

Feb 14, 2022
SELL
$7.9 - $10.19 $184,583 - $238,089
-23,365 Reduced 1.22%
1,890,475 $15.1 Million
Q3 2021

Nov 15, 2021
BUY
$8.38 - $10.18 $1.1 Million - $1.33 Million
130,872 Added 7.34%
1,913,840 $18.6 Million
Q2 2021

Aug 16, 2021
SELL
$9.9 - $11.56 $879,684 - $1.03 Million
-88,857 Reduced 4.75%
1,782,968 $17.7 Million
Q1 2021

May 14, 2021
SELL
$10.34 - $12.81 $629,240 - $779,552
-60,855 Reduced 3.15%
1,871,825 $21.6 Million
Q4 2020

Mar 01, 2021
SELL
$8.61 - $11.04 $151,622 - $194,414
-17,610 Reduced 0.9%
1,932,680 $18.7 Million
Q3 2020

Nov 13, 2020
BUY
$8.57 - $12.69 $127,804 - $189,245
14,913 Added 0.77%
1,950,290 $17.6 Million
Q2 2020

Aug 14, 2020
SELL
$8.12 - $13.12 $470,797 - $760,697
-57,980 Reduced 2.91%
1,935,377 $23.9 Million
Q1 2020

May 15, 2020
BUY
$6.69 - $13.45 $613,105 - $1.23 Million
91,645 Added 4.82%
1,993,357 $17.9 Million
Q4 2019

Feb 14, 2020
BUY
$6.53 - $10.72 $1.16 Million - $1.9 Million
177,129 Added 10.27%
1,901,712 $18.6 Million
Q3 2019

Nov 14, 2019
BUY
$6.16 - $9.6 $1.17 Million - $1.82 Million
190,023 Added 12.38%
1,724,583 $11.9 Million
Q2 2019

Aug 15, 2019
SELL
$8.12 - $15.72 $2.46 Million - $4.76 Million
-302,680 Reduced 16.47%
1,534,560 $0
Q1 2019

May 14, 2019
SELL
$15.58 - $20.01 $8.86 Million - $11.4 Million
-568,823 Reduced 23.64%
1,837,240 $0
Q4 2018

Feb 13, 2019
BUY
$14.59 - $23.84 $14.4 Million - $23.5 Million
984,975 Added 69.31%
2,406,063 $37.1 Million
Q3 2018

Nov 14, 2018
SELL
$21.06 - $25.65 $276,370 - $336,604
-13,123 Reduced 0.91%
1,421,088 $0
Q2 2018

Aug 14, 2018
BUY
$16.77 - $24.71 $862,447 - $1.27 Million
51,428 Added 3.72%
1,434,211 $0
Q1 2018

May 14, 2018
SELL
$16.68 - $22.07 $11,025 - $14,588
-661 Reduced 0.05%
1,382,783 $0
Q4 2017

Feb 09, 2018
BUY
$11.23 - $19.1 $156,433 - $266,063
13,930 Added 1.02%
1,383,444 $0
Q3 2017

Nov 13, 2017
BUY
$15.41 - $32.17 $21.1 Million - $44.1 Million
1,369,514
1,369,514 $0

Others Institutions Holding TEVA

# of Institutions
624
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email